Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 15 Sept 2026 for Neurocrine Biosciences INC. Read the official filing
Filing timeline
BuySaleMatt Abernethy
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Matt Abernethy: trading record in brief
Matt Abernethy is a declared insider of Neurocrine Biosciences Inc (finance chief), with filings sourced from SEC (Form 4). We count 29 filings; the first trade dates from 1 December 2021 and the latest from 14 September 2026.
Sales make up the whole of the open-market record (10 sales, €1.7M). Outside the open market, there are 8 share grants and 10 option exercises. 2026 to date brings no purchases and 1 sale.
On 15 September 2026 came the latest disclosure, a share grant in Neurocrine Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Matt Abernethy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
5,020 shares0Common StockSEC:0001724097-26-000010:0
2,709 shares@ US$156.22Common StockSEC:0001724097-26-000010:1
2,311 shares@ US$157.1981Common StockSEC:0001724097-26-000010:2
2,249 shares0Common StockSEC:0001724097-26-000007:0
1,151 shares@ US$123.102.5% of flowCommon StockSEC:0001724097-26-000005:1
1,210 shares@ US$124.122.6% of flowCommon StockSEC:0001724097-26-000005:3
1,385 shares@ US$124.123.0% of flowCommon StockSEC:0001724097-26-000005:5
5,378 shares@ US$124.1211.7% of flowCommon StockSEC:0001724097-26-000005:7
2,133 shares0Common StockSEC:0001724097-26-000005:0
2,241 shares0Common StockSEC:0001724097-26-000005:2
2,566 shares0Common StockSEC:0001724097-26-000005:4
9,968 shares0Common StockSEC:0001724097-26-000005:6
1,368 shares@ US$136.063.2% of flowCommon StockSEC:0001724097-26-000003:1
2,437 shares0Common StockSEC:0001724097-26-000003:0
2,566 shares0Common StockSEC:0000914475-25-000055:0
1,860 shares0Common StockSEC:0000914475-25-000046:0
2,436 shares0Common StockSEC:0000914475-25-000020:0
1,283 shares@ US$152.87283.9% of flowCommon StockSEC:0000914475-25-000020:1
14,100 shares@ US$73.6019.6% of flowCommon StockSEC:0000914475-24-000193:0
900 shares@ US$73.601.3% of flowCommon StockSEC:0000914475-24-000170:0
15,000 shares@ US$73.6021.2% of flowCommon StockSEC:0000914475-24-000121:0
1,352 shares@ US$132.84883.5% of flowCommon StockSEC:0000914475-24-000067:0
1,280 shares@ US$142.18783.5% of flowCommon StockSEC:0000914475-24-000043:0
1,283 shares@ US$140.71613.5% of flowCommon StockSEC:0000914475-24-000022:0
2,132 shares@ US$107.39144.4% of flowCommon StockSEC:0001209191-23-047127:0
25 of 29 declarations
